Navigation Links
Neuralstem's ALS Trial on Clinical Hold
Date:2/20/2009

ROCKVILLE, Md., Feb. 20 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Alternext US: CUR) announced today its spinal cord stem cell trial to treat ALS is on clinical hold and that the Federal Drug Administration (FDA) has provided the Company with specific comments, questions and recommendations for modifications to its protocol.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061221/DCTH007LOGO )

"The FDA has presented us with their review of our entire Investigational New Drug (IND) application," said Richard Garr, Neuralstem's President & CEO. "They have asked for some additional information regarding our product manufacturing process and pre-clinical studies, as well as our novel clinical delivery injection device and technique. The Company believes that it can provide this information in an expeditious manner."

"The Agency has also requested various modifications to the protocol and eligibility criteria for patients in the trial, as well as slight changes to the timing of the surgeries," Mr. Garr continued. "We are evaluating these changes and will respond accordingly. The Agency had extensive 'non hold' comments, requests for information, and recommendations. These primarily concerned issues that will need to be addressed for final product manufacturing and testing. We are appreciative of their work in this area."

"Over all we believe the Agency's comments and recommendations are extremely helpful," Garr concluded. "We are evaluating them carefully, and expect to reach agreement with the Agency on all matters so that the trial can be approved and move forward."

About Neuralstem

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to contro
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 Professional Compounding Centers ... medicine by awarding the three best scientific presentations ... (EuPFI) conference . The Formulating Better Medicines ... in Athens, Greece , includes ... and professionals, from which three winners will be ...
(Date:8/21/2014)... MENLO PARK, Calif. , Aug. 21, 2014 /PRNewswire/ ... company in the emerging field of regenerative medicine, announced ... ("Nat") Ricciardi to the Company,s newly expanded Board of ... now comprises eight directors, three of whom are independent. ... years of experience working with emerging growth companies. He ...
(Date:8/20/2014)... Aug. 20, 2014 The National Association ... latest results achieved by the real-time, pseudoephedrine (PSE) ... National Precursor Log Exchange (NPLEx), automatically blocks unlawful ... down meth offenders and make arrests. Data released ... Kansas blocked the sale of more ...
Breaking Medicine Technology:Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... 2011 Medizone International, Inc. (MZEI:OB MZEI:QB) reports ... Patent No 2735739 for processes and systems relating ... AsepticSure™ hospital disinfection product. Medizone,s ... significance of this Grant: "This foundational lead patent ...
... Leading event organiser UBM has announced a record ... pharmaceutical events including CPhI Worldwide for pharmaceutical ingredients, ... for equipment, machinery and technology and the new ... Frankfurt, Germany from the 25th to 27th October ...
Cached Medicine Technology:Canadian Patent Issued to Medizone International for AsepticSureā„¢ Disinfection Technology 2Record Year for UBM's Pharma Events in Frankfurt 2Record Year for UBM's Pharma Events in Frankfurt 3Record Year for UBM's Pharma Events in Frankfurt 4
(Date:8/21/2014)... Physicians (CHEST) announces the immediate release of Care ... and Disasters: CHEST Consensus Statement today in the ... while the global health-care community cares for ... aims to guide ethical decision-making, coordination of care, ... was developed by over 100 clinicians and experts ...
(Date:8/21/2014)... When children go back to school, they ... them to become sick and risk missing school. It is ... them fight these germs to ensure a successful school year. ... that with its XFactor program. , The XFactor program supports ... Children ages 4 and up can receive 30-day supplies of ...
(Date:8/21/2014)... 21, 2014 CarePoint Health is ... P. Patel, MD, and Sujoy Menon, MD, have ... Patel and Dr. Menon to the community. CarePoint ... diagnostic imaging services to patients in Hudson County ... Christ Hospital and Hoboken University Medical Center. Our ...
(Date:8/21/2014)... of Utah scientists have developed a genetically engineered line ... to new research on epilepsy, Alzheimer,s and other diseases. ... changes in degree of fluorescence in response to different ... cells called astrocytes and microglia, to be studied in ... possibility to decipher how the brain works," said ...
(Date:8/21/2014)... Individuals with schizophrenia often have trouble engaging in ... new study from San Francisco State University suggests the ... of effort required to complete tasks. , The research, ... Journal of Abnormal Psychology , can assist health ... and help those patients function normally by breaking up ...
Breaking Medicine News(10 mins):Health News:CHEST releases new expert guidance in care of the critically ill and injured 2Health News:MedX Pharmacy Helps with Back to School Preparation 2Health News:Two Top Radiologists Join CarePoint Health 2Health News:Mouse model for epilepsy, Alzheimer's gives window into the working brain 2Health News:Difficulty assessing effort drives motivation deficits in schizophrenia, study finds 2
... Javier Menendez and colleagues from Northwestern University have found ... drug found to be effective in reducing the cancer ... have Her-2/neu receptors (Human Epidermal Growth factor Receptor type ... are more aggressive and the activation of the receptors ...
... name suggests is the excessive accumulation of fat in the ... may be a crucial one in explaining the association between ... concluded from the study that persons with fatty liver may ... ,The study was conducted among a group of 1,455 individuals ...
... Cape Town, South Africa have found effective results using ... women with high-risk for //,cervical cancer using low resource ... study results showed that the test and treat program ... of cervical cancer and precancerous cervical lesions. ...
... in action or effect of a particular drug than the individual ... in the present scenario where the avian bird flu is posing ... ,Tamiflu is a prescribed drug for seasonal flu, ... H5N1 bird flu circulating in Asia and reported in other areas ...
... Association for Cancer Research has leaned in a big way ... garlic after several studies presented at the meeting extolled on ... with irrefutable news, experts are now of the view that ... change the way you eat, in other words diet modification ...
... Delhi: India, which is currently ... flu, is thinking of importing ... for poultry said a government ... also has set up special ...
Cached Medicine News:Health News:Primrose oil reduces Breast cancer cell growth 2Health News:Persons With Fatty Liver More Prone For Hypertension 2Health News:Two screen test and treat screening for cervical cancer 2Health News:Tamiflu Shortage Can Be Better Handled By Combining It With Probenecid 2
... plates in mind, Pipetman Ultra Multichannel ... applications: PCR* sequencing, immunology assays, series ... with Diamond Tips from Gilson's patented ... maximize performance and assure productivity.,* PCR ...
... variety of applications. • Whole pipette is autoclavable ... rotated against the handle to work in a ... towards the microtiter plate. • The special nose ... pipette tips, and provides a firm, parallel fit. ...
... precision, ergonomics, and value!, Comfortable feel ... contoured handle , Finer control while pipetting ... Stress-free tip ejection with long, lever tip ... and sterilization without the need for recalibration ...
... precision, ergonomics, and value!, Comfortable feel ... contoured handle , Finer control while pipetting ... Stress-free tip ejection with long, lever tip ... and sterilization without the need for recalibration ...
Medicine Products: